Perspective Therapeutics ... (CATX)
AMEX: CATX
· Real-Time Price · USD
3.63
0.46 (14.51%)
At close: Jun 16, 2025, 3:59 PM
3.60
-0.69%
After-hours: Jun 16, 2025, 07:55 PM EDT
14.51% (1D)
| Bid | 3.58 |
| Market Cap | 269.08M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -79.28M |
| EPS (ttm) | -1.23 |
| PE Ratio (ttm) | -2.95 |
| Forward PE | -2.5 |
| Analyst | Buy |
| Ask | 3.6 |
| Volume | 1,951,090 |
| Avg. Volume (20D) | 996,652 |
| Open | 3.20 |
| Previous Close | 3.17 |
| Day's Range | 3.04 - 3.63 |
| 52-Week Range | 1.60 - 16.55 |
| Beta | 1.12 |
About CATX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CATX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CATX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+29.29%
Perspective Therapeutics shares are trading higher...
Unlock content with
Pro Subscription
6 months ago
-51.38%
Perspective Therapeutics shares are trading lower. The company announced initial results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET.
